Aptose Biosciences Inc.
APS.TOTSXHealthcare● Active
$2.19
$-0.01(-0.45%)
Market Cap$5589820
P/E Ratio—
52W High$2.59
52W Low$1.02
Aptose Biosciences Inc. (APS.TO) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · APS.TO · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.00B | $0.01B | $0.01B | $0.05B | $0.08B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.01B | $0.01B | $0.01B | $0.05B | $0.08B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.01B | $0.01B | $0.01B | $0.05B | $0.08B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Total Current Liabilities | $0.01B | $0.00B | $0.02B | $0.01B | $0.01B |
| Long-Term Debt | $0.03B | $0.01B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.04B | $0.01B | $0.02B | $0.01B | $0.01B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.57B) | ($0.54B) | ($0.52B) | ($0.46B) | ($0.42B) |
| Total Stockholders Equity | ($0.03B) | ($0.00B) | ($0.00B) | $0.04B | $0.07B |
| Total Liab & Equity(computed) | $0.01B | $0.01B | $0.01B | $0.05B | $0.08B |
| Debt Summary | |||||
| Total Debt | $0.03B | $0.01B | $0.00B | $0.00B | $0.00B |
| Net Debt | $0.02B | ($0.01B) | ($0.01B) | ($0.04B) | ($0.04B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Aptose Biosciences Inc. data
About Aptose Biosciences Inc. (APS.TO) Balance Sheet
Aptose Biosciences Inc. (APS.TO) balance sheet shows total assets of $0.01B with cash of $0.00B. Total liabilities are $0.04B, total debt $0.03B, and stockholders equity ($0.03B).
Frequently asked questions
APS.TO · 4 questionsAptose Biosciences Inc. has total debt of $0.03B with net debt of $0.02B.
APS.TO total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10